Review of the United States universal varicella vaccination program: Herpes zoster incidence rates, cost-effectiveness, and vaccine efficacy based primarily on the Antelope Valley Varicella Active Surveillance Project data

In a cooperative agreement starting January 1995, prior to the FDA's licensure of the varicella vaccine on March 17, the Centers for Disease Control and Prevention (CDC) funded the Los Angeles Department of Health Services’ Antelope Valley Varicella Active Surveillance Project (AV-VASP). Since...

Descripción completa

Detalles Bibliográficos
Autores principales: Goldman, G.S., King, P.G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3759842/
https://www.ncbi.nlm.nih.gov/pubmed/22659447
http://dx.doi.org/10.1016/j.vaccine.2012.05.050

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3759842/
https://www.ncbi.nlm.nih.gov/pubmed/22659447
http://dx.doi.org/10.1016/j.vaccine.2012.05.050

Ejemplares similares